The determination of the glucurono-conjugated position in three
bile alcohol glucuronides secreted in bile of a patient with
cerebrotendinous xanthomatosis was carried out by a nuclear magnetic resonance study. The bile sample was extracted with
ethanol and chromatographed on an ion-exchange column, a reverse-phase partition column and a
silica gel column to isolate glucurono-conjugates of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25-tetrol,
5 beta-cholestane-3 alpha, 7 alpha 12 alpha, 23-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol.
Proton and 13C nuclear magnetic resonance spectra of the two biliary
bile alcohol glucuronides, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25-tetrol
glucuronide and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol
glucuronide were identical with those of the synthetic
glucuronide 7 alpha, 12 alpha, 25-trihydroxy-5 beta-cholestane-3 alpha-O beta-D-glucopyranosyluronic
acid and the isolated
glucuronide 3 alpha, 7 alpha, 12 alpha, 25-tetrahydroxy-5 beta-cholestane-23-O-beta-D-glucopyranosyluronic
acid from urine of a patient with
cerebrotendinous xanthomatosis, respectively. Hence, the glucurono-conjugated positions of the biliary 25-tetrol
glucuronide and the biliary 23,25-pentol
glucuronide were C-3 and C-23, respectively. By comparison of the 13C chemical shift data with that of the unconjugated
bile alcohol,
5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23-tetrol, the glucurono-conjugated position of the natural 23-tetrol
glucuronide was determined to be C-23. Thus, the natural 23-tetrol
glucuronide can be formulated as 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestane-23-O-beta-D-glucopyranosyluronic
acid.